ACM Research (ACMR) Q4 2025 earnings review
Record Revenue Shadowed by Crashing Margins and Contracting Shipments
ACM Research delivered record full-year revenue of $901 million, beating its internal targets. However, the quality of these results is alarming. Q4 Operating Income plummeted 48% YoY, and Gross Margin crashed to 40.9%—dropping below the company's long-term 42-48% target model. Most concerning is a stark divergence in the leading indicators: while management praised "strong execution" and guided for 25% revenue growth in FY26, total FY25 shipments actually contracted by 12.2%. The company is clearly facing pricing pressure from rising domestic competition in China, though it is attempting to counter this with rapid global expansion and new product rollouts.
🐂 Bull Case
Management confidently guided FY26 revenue to $1.08B-$1.175B (a ~25% YoY acceleration), showing conviction that new tool evaluations (Tahoe, SPM, Furnace) will convert to recognized sales.
ACM ended the year with $845 million in net cash—supercharged by equity sales of its ACM Shanghai subsidiary. The balance sheet is heavily fortified to fund global expansion and R&D without requiring debt.
🐻 Bear Case
Gross margin broke below the 42-48% target floor, hitting 40.9% in Q4. Management explicitly cited "competitive dynamics for a few semi-critical products," signaling that price wars in China are taking a toll.
Despite reporting 15% revenue growth for the year, total equipment shipments fell 12.2% to $854 million. Because shipments are the leading indicator for future revenue recognition, this raises serious doubts about the achievability of the aggressive 2026 revenue guidance.
⚖️ Verdict: 🔴
Bearish. The headline revenue numbers and ambitious guidance mask severe underlying degradation. Margins are compressing, OpEx is inflating, and shipments are shrinking. The "growth" story currently lacks profitable flow-through.
Key Themes
Gross Margin Breaks Target Floor Amid Pricing Pressure
Gross margin decelerated sharply to 40.9% in Q4, down from 49.6% a year ago and 42.0% last quarter. More critically, it broke below ACM's stated 42-48% long-term target range. Management directly attributed this to "competitive dynamics for a few semi-critical products" as well as inventory-related charges. This is a severe red flag indicating that rising domestic competition in China is finally forcing ACM to sacrifice price to maintain market share.
Data Contradicts Narrative: Shipments in Decline
Management framed 2025 as a year of "strong execution" that outperformed the broader China WFE market. However, a crucial data point contradicts this: total shipments for FY25 fell 12.2% YoY to $854 million (Q4 shipments specifically fell 13.6% YoY). Because ACM only recognizes revenue upon tool acceptance, declining shipments point to a thinning backlog. If tools aren't shipping today, revenue recognition tomorrow becomes mathematically difficult, casting a shadow over their optimistic 2026 targets.
Operating Leverage is Reversing
Operating Expenses climbed 15% in Q4 to $76.9 million, outpacing the 9.4% revenue growth. For the full year, OpEx soared 20.8% while revenue grew 15.2%. This structural inflation in SG&A and R&D, combined with falling gross margins, caused operating income to collapse 47.6% YoY in Q4. ACM is getting bigger, but drastically less profitable.
Accelerating Global Footprint (Macro Strategy)
Facing a highly complex geopolitical and tariff environment, ACM is aggressively diversifying outside of mainland China. In Q4, they delivered multiple 300mm single-wafer cleaning systems to a foundry in Singapore (a first) and secured advanced packaging orders from a North American tech company. Concurrently, investments in their Oregon facility are accelerating, with operations scheduled to begin in H2 2026. This geographic de-risking is vital for long-term survival.
Advanced Technology Deployments Yielding Results
ACM is successfully proving out its complex new technology platforms beyond basic cleaning. The company delivered its first horizontal panel electroplating tool (Ultra ECP ap-p) and the advanced Ultra Lith BK photoresist hardening tool. These high-end segments (ECP, furnace, and advanced packaging) significantly outgrew the core cleaning business in Q4, growing ~24% YoY combined and proving ACM's capability to cross-sell to existing clients.
ACM Shanghai Serves as a Funding ATM
ACM possesses a unique competitive advantage: its dual-listing structure. The company holds massive net cash of $845 million, primarily generated by selling shares of its STAR Market-listed subsidiary, ACM Shanghai. Following a $623M raise in September 2025, they sold another $111M in February 2026. This setup allows them to fund aggressive capacity expansions and R&D indefinitely, completely isolated from high debt costs.
Other KPIs
Decelerating heavily. Grew only 3.0% YoY compared to $155.2M in 24Q4. As ACM's foundational segment (representing 65% of Q4 sales), this stalling growth rate puts intense pressure on newer products to carry the company's ambitious targets.
Reversing violently. Dropped 74% YoY from $31.1 million. The bottom line was decimated by the margin crunch and rising expenses. Diluted EPS collapsed to just $0.11.
Guidance
Accelerating. The midpoint of $1.127 billion implies 25.1% YoY growth, a sharp step up from the 15.2% growth achieved in FY25. Management expects this to be driven by new tool contributions (Tahoe, SPM, furnace) and momentum in advanced packaging. However, this target appears extremely aggressive given the 12% drop in FY25 shipments.
Key Questions
Shipment Contraction vs Revenue Guidance
Total shipments declined 12.2% in FY25, yet you are guiding for 21-30% revenue growth in FY26. Given the standard delay between shipments and acceptances, what mechanics bridge this mathematical gap? Are you expecting an unprecedented wave of rapid conversions from the existing field inventory?
Gross Margin Floor
Gross margin fell to 40.9% this quarter, violating the 42-48% long-term target model. You cited 'competitive dynamics.' Is this intense pricing pressure isolated to legacy cleaning products, or is the broader domestic WFE market in China structurally compressing margins?
Inventory Write-Downs
You noted inventory-related charges impacting Q4 margins. Does this relate to the strategic raw material purchasing you executed earlier in the year to front-run supply chain risks, or are these write-downs on finished goods that failed to find buyers?
Oregon Facility Operating Costs
With the Oregon facility accelerating toward H2 2026 operations, how should we model the incremental OpEx and CapEx burden on the P&L through the transition period?